You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

prophylactic peripheral iridectomy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Amputation, Neuroma Amputation, Phantom Limb Pain Trial (Targeted Muscle Re-innervation, Regenerative Peripheral Nerve

Not yet recruiting
  • Amputation
  • +3 more
  • Targeted Muscle Re-innervation
  • +2 more
  • (no location specified)
Jul 4, 2022

Congenital Cataract, Aphakic Glaucoma Trial in Guangzhou (PPI group, cataract extraction)

Completed
  • Congenital Cataract
  • Aphakic Glaucoma
  • PPI group
  • cataract extraction
  • Guangzhou, Guangdong, China
  • +1 more
Mar 9, 2019

Lung Tumor Trial in High Point, Winston-Salem (risedronate, Matching )

Active, not recruiting
  • Lung Neoplasm
  • High Point, North Carolina
  • +1 more
Mar 1, 2022

Pseudophakic Bullous Keratopathy, Anterior Chamber Intraocular Lens Trial in Alexandria (Descemet membrane endothelial

Unknown status
  • Pseudophakic Bullous Keratopathy
  • Anterior Chamber Intraocular Lens
  • Descemet membrane endothelial keratoplasty DMEK
  • +3 more
  • Alexandria, Egypt
    Faculty of Medicine
Aug 10, 2020

Shivering Trial in Karachi (Tramadol with Ketamine, Tramadol)

Recruiting
  • Shivering
  • Karachi, Sindh, Pakistan
    Muhammad Arif
Nov 15, 2023

Primary Angle Glaucoma Closure Suspect Trial in Denmark (Iridotomy)

Recruiting
  • Primary Angle Glaucoma Closure Suspect
  • Iridotomy
  • Aalborg, Denmark
  • +4 more
Oct 4, 2023

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 21, 2022

Pain Syndrome Trial in Guangzhou (Etoricoxib)

Completed
  • Pain Syndrome
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Jan 29, 2022

NSCLC Stage IV, ALK Fusion Protein Expression Trial (Peptide vaccine)

Not yet recruiting
  • NSCLC Stage IV
  • ALK Fusion Protein Expression
  • Peptide vaccine
  • (no location specified)
Jul 21, 2023

Surgical Injury Trial in Wuhan (Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato], 0.9% saline)

Not yet recruiting
  • Surgical Injury
  • Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]
  • 0.9% saline
  • Wuhan, Hubei, China
    Department of Critical Care Medicine, Union Hospital, Tongji Med
Jul 12, 2022

Lung Transplant; Complications, Mechanical, Lung Transplant; Complications, Bleeding Trial in Baltimore (Topical epinephrine,

Completed
  • Lung Transplant; Complications, Mechanical
  • +3 more
  • Topical epinephrine
  • Placebos
  • Baltimore, Maryland
  • +1 more
Jan 21, 2023

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
Has Results
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

MDS, Leukemia, Myeloid, Acute Trial in London (DLI will be administered to all patients at Month 4 (+/- 20 days) after stem cell

Unknown status
  • Myelodysplastic Syndromes
  • Leukemia, Myeloid, Acute
  • DLI will be administered to all patients at Month 4 (+/- 20 days) after stem cell transplant regardless of peripheral blood CD3 chimerism (including if they have full donor chimerism)
  • DLI will be administered from Month 6 (+/- 20 days) after stem cell transplant according to institutional practice
  • London, United Kingdom
    King's College Hospital NHS Foundation Trust
Apr 1, 2020

Sickle Cell Disease Trial in Memphis (Plerixafor)

Recruiting
  • Sickle Cell Disease
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 11, 2023

Satisfaction & Efficacy of Compression Using Surgical Gloves in

Active, not recruiting
  • Breast Cancer
  • Colorectal Cancer
  • Chilled gloves
  • Surgical gloves
  • Caluire-et-Cuire, France
  • +1 more
Nov 21, 2022

Peripheral T-cell Lymphoma Trial in Worldwide (Belinostat)

Completed
Has Results
  • Peripheral T-cell Lymphoma
  • Duarte, California
  • +116 more
Oct 14, 2021

Premalignant Vulvar Lesion, Benign Vulvar Lesion Trial in Saint Louis (Cefazolin)

Completed
Has Results
  • Premalignant Vulvar Lesion
  • Benign Vulvar Lesion
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 26, 2022

Acute Gastrointestinal Bleeding Trial in Shanghai (embolization)

Recruiting
  • Acute Gastrointestinal Bleeding
  • embolization
  • Shanghai, China
    Shanghai 10th People's Hospital
Sep 22, 2022

Leukemia, Myeloid, Acute, MDS Trial in Wurzburg (TCM allogeneic humane central memory T cells, cryopreserved)

Completed
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • TCM allogeneic humane central memory T cells, cryopreserved
  • Wurzburg, Germany
    University Hospital Wuerzburg - Department of Medicine II
Jul 12, 2022

Shivering Trial in Cairo (Pethidine, Acetaminophen, Dexamethasone)

Active, not recruiting
  • Shivering
  • Cairo, Egypt
    Ain Shams University Hospitals
Sep 14, 2022

MPS IIIA, Sanfilippo Syndrome, Sanfilippo A Trial in Australia, Spain, United States (ABO-102)

Active, not recruiting
  • MPS IIIA
  • +3 more
  • ABO-102
  • Columbus, Ohio
  • +4 more
Nov 8, 2022

Migraine Trial in Tanta (zolmitriptanee, topiramate, Valproate)

Recruiting
  • Migraine
  • Tanta, Kafrelsheikh, Egypt
    Kafrelsheikh University
Oct 13, 2023

Spinal Cord Injuries, Autonomic Dysreflexia Trial in Detroit (Mild Intermittent Hypoxia, Sham)

Not yet recruiting
  • Spinal Cord Injuries
  • Autonomic Dysreflexia
  • Mild Intermittent Hypoxia
  • Sham
  • Detroit, Michigan
    John D. Dingell VA Medical Center, Detroit, MI
Jun 15, 2022

Amputation Neuroma Trial in Beijing (preventive regenerative peripheral nerve interface reconstruction)

Recruiting
  • Amputation Neuroma
  • preventive regenerative peripheral nerve interface reconstruction
  • Beijing, China
    Peking University People's Hospital
Sep 21, 2022

Biliary Atresia, Cholangitis, Anti-Bacterial Agents Trial (Basic treatment: sulperazone + ursodeoxycholic acid + compound

Not yet recruiting
  • Biliary Atresia
  • +2 more
  • Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
  • Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor
  • (no location specified)
Jun 28, 2023